These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 20970774)

  • 1. Long-term results of photodynamic therapy for choroidal neovascularization in Japanese patients with pathologic myopia.
    Hayashi K; Ohno-Matsui K; Shimada N; Moriyama M; Hayashi W; Wang J; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2011 Jan; 151(1):137-147.e1. PubMed ID: 20970774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of myopic choroidal neovascularization: A systematic review and meta-analysis.
    Zhang XJ; Chen XN; Tang FY; Szeto S; Ling XT; Lin ZX; Tham CC; Pang CP; Chen LJ; Yam JC
    Surv Ophthalmol; 2023; 68(6):1011-1026. PubMed ID: 37517683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DIFFUSE CHORIORETINAL ATROPHY IN CHINESE HIGH MYOPIA: The ZOC-BHVI High Myopia Cohort Study.
    Liu R; Guo X; Xiao O; Li Z; Zhang J; Lee JTL; Wang D; Sankaridurg P; Jong M; He M
    Retina; 2020 Feb; 40(2):241-248. PubMed ID: 31972793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chorioretinal Atrophic Lesions Evolution in Patients with Quiescent Myopic Choroidal Neovascularization Followed for More Than 10 Years.
    Ferreira AM; Vilares-Morgado R; Lima-Fontes M; Falcão M; Falcão-Reis F; Carneiro Â
    Clin Ophthalmol; 2024; 18():1381-1390. PubMed ID: 38770398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes.
    Kang MT; Wang N; Xu W; Yusufu M; Liu W; Tian J; Qi Y
    BMC Ophthalmol; 2024 Mar; 24(1):118. PubMed ID: 38481176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antivascular endothelial growth factor treatment for myopia choroidal neovascularisation: a systematic review and meta-analysis of randomised controlled trials.
    Dong L; Li G; Song Z; Cheng X; Bai J; Zhang C
    BMJ Open; 2023 Jul; 13(7):e067921. PubMed ID: 37474162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of myopia management: A systematic review.
    Agyekum S; Chan PP; Zhang Y; Huo Z; Yip BHK; Ip P; Tham CC; Chen LJ; Zhang XJ; Pang CP; Yam JC
    Front Public Health; 2023; 11():1093836. PubMed ID: 36923029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of clinical practice guidelines for myopic macular degeneration.
    Chen Y; Han X; Gordon I; Safi S; Lingham G; Evans J; Li J; He M; Keel S
    J Glob Health; 2022; 12():04026. PubMed ID: 35356661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization.
    Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION: BRILLIANCE, a 12-Month, Randomized, Double-Masked Study.
    Chen Y; Sharma T; Li X; Song Y; Chang Q; Lin R; Egger A; Foo A; Gekkieva M; Lai TYY
    Retina; 2019 Oct; 39(10):1985-1994. PubMed ID: 30204730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel classification of high myopia into anterior and posterior pathologic subtypes.
    Ludwig CA; Shields RA; Chen TA; Powers MA; Wilkin Parke D; Moshfeghi AA; Moshfeghi DM
    Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1847-1856. PubMed ID: 30030628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization.
    Tan CS; Sadda SR
    Clin Ophthalmol; 2017; 11():1741-1746. PubMed ID: 29026284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging treatment options for myopic choroidal neovascularization.
    El Matri L; Chebil A; Kort F
    Clin Ophthalmol; 2015; 9():733-44. PubMed ID: 25987831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myopic choroidal neovascularisation: current concepts and update on clinical management.
    Wong TY; Ohno-Matsui K; Leveziel N; Holz FG; Lai TY; Yu HG; Lanzetta P; Chen Y; Tufail A
    Br J Ophthalmol; 2015 Mar; 99(3):289-96. PubMed ID: 24990871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Statement of the Deutsche Ophthalmologische Gesellschaft (German Ophthalmological Society), the Retinologische Gesellschaft (German Retina Society) and the Berufsverband der Augenärzte Deutschlands (German Professional Association of Ophthalmologists) on the therapy of choroidal neovascularization in myopia. State: March 2014].
    Pauleikhoff D; Bertram B; Claessens D
    Ophthalmologe; 2014 Mar; 111(3):229-34. PubMed ID: 24633460
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of foveal-sparing with foveal-involving photodynamic therapy for myopic choroidal neovascularization.
    Tan CS; Chew MC; Lim TH
    Eye (Lond); 2014 Jan; 28(1):17-22. PubMed ID: 24051405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy.
    Tan CS; Chew MC; Lim KH; Lim TH
    Int J Ophthalmol; 2013; 6(3):327-30. PubMed ID: 23826527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of myopic choroidal neovascularization].
    Voykov B; Ziemssen F; Bartz-Schmidt KU
    Ophthalmologe; 2012 Aug; 109(8):766-9. PubMed ID: 22828745
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.